Urban Training for COPD Patients

April 26, 2018 updated by: Judith Garcia-Aymerich

Effectiveness of an Intervention of Urban Training in Patients With Chronic Obstructive Pulmonary Disease (COPD): a Randomised Controlled Trial

This project plans on a training intervention by using public spaces and urban walkable trails, adapted to each patient needs and capabilities. Primary objective is to assess 12 months effectiveness of the intervention with respect to: (primary outcome): physical activity level, and (secondary outcomes): COPD admissions, exercise capacity, body composition, quality of life, and mental health.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

412

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08003
        • Hospital del Mar
      • Barcelona, Spain, 08036
        • Hospital Clínic
    • Barcelona
      • Badalona, Barcelona, Spain, 08916
        • Hospital Germans Trias i Pujol
      • Mataró, Barcelona, Spain, 08303
        • CAP Maresme
      • Viladecans, Barcelona, Spain, 08840
        • CAP Maria Bernades

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 130 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • age > 45 years
  • COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
  • clinical stability, defined as at least 4 weeks without antibiotics or oral corticosteroids.

Exclusion Criteria:

  • living >6 months/year outside of the included municipalities,
  • living to a distance higher than 500 meters to any of the urban trails used for the study,
  • mental disability according to the Mini Mental State Examination in its validated Spanish version
  • comorbidity that could interfere with study tests (e.g., lower limb amputation)
  • severe psychiatric disease or severe comorbidity limiting survival at one year, according to medical history.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Urban training Intervention
Patients will be advised to walk in the defined urban trails.
Recommendation to walk a minimum of 5 days per week in urban walkable trails appropriate for the patient.
No Intervention: Usual care
Patients will continue their usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in physical activity
Time Frame: Baseline and 12 months follow-up
Change in physical activity between baseline and 12 months follow-up, as defined by average steps per day measured with an activity monitor
Baseline and 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
COPD admissions to emergency-room or hospital
Time Frame: 12 months follow-up
12 months follow-up
Change in exercise capacity, as measured with 6-min walking distance
Time Frame: Baseline and 12 months
Change in exercise capacity between baseline and 12 months, as measured with 6-min walking distance
Baseline and 12 months
Change in body weight and composition
Time Frame: Baseline and 12 month
Change in body weight and composition between baseline and 12m follow-up, as measured with bioimpedance
Baseline and 12 month
Change in quality of life
Time Frame: Baseline and 12-m
Change in quality of life between baseline and 12-m follow-up, as measured with CAT and CCQ
Baseline and 12-m
Change in anxiety and depression symptoms
Time Frame: Baseline and 12 months
Change in anxiety and depression symptoms between baseline and 12 months follw-up, as measured with the HAD scale
Baseline and 12 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in cognitive status
Time Frame: Baseline and 12months
Changes between baseline and 12 months follow-up in cognitive status measured with the Phototest
Baseline and 12months
Changes in the Clinical PPAC
Time Frame: Baseline and 12months
Changes between baseline and 12 months follow-up in phsyical activity measured with the Clinical visit "PROactive Physical Activity in COPD" instrument
Baseline and 12months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

July 1, 2013

Primary Completion (Actual)

February 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

July 3, 2013

First Submitted That Met QC Criteria

July 9, 2013

First Posted (Estimate)

July 11, 2013

Study Record Updates

Last Update Posted (Actual)

April 27, 2018

Last Update Submitted That Met QC Criteria

April 26, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Other Study ID Numbers

  • PI11/01283
  • 147/2011 (Other Grant/Funding Number: SEPAR)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Obstructive Pulmonary Disease (COPD)

Clinical Trials on Urban training

3
Subscribe